+1 858 550 6152 msilverman@cooley.com
Matt Silverman focuses on mergers and acquisitions, general corporate matters and securities law. Matt regularly advises publicly traded companies with respect to corporate governance, takeover preparedness and SEC reporting.
Download full bio
Principia Biopharma Agrees to Sell to Sanofi for Approximately $3.68 Billion
Sunrun to Acquire Vivint Solar for Enterprise Value of $3.2 Billion
Portola Agrees to Sell to Alexion for $1.41 Billion
Forty Seven Agrees to Sell to Gilead for $4.9 Billion
Avedro Sells to Glaukos
View all
Mergers & Acquisitions
Film, Music, Surfing and Travel
Fordham University School of Law JD, cum laude, 2012
University of VermontBA, Economics and Political ScienceHonors Program, 2006
California
New York
Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company October 28, 2020
Principia Biopharma Agrees to Sell to Sanofi for Approximately $3.68 Billion August 18, 2020
Portola Agrees to Sell to Alexion for $1.41 Billion May 5, 2020
+1 858 550 6152 office msilverman@cooley.com
4401 Eastgate MallSan Diego, CA 92121-1909